Birth Control Options for Teens with Heavy Menstrual Cycles

First-Line Options

The American Academy of Pediatrics recommends the levonorgestrel IUD as the most effective birth control option for teens with heavy menstrual bleeding, providing excellent menstrual suppression while offering long-term contraception without estrogen-related risks 1, 2
The levonorgestrel IUD provides significant improvement in dysmenorrhea and heavy menstrual bleeding in adolescents, with high satisfaction and continuation rates (≥75% at 1 year) 1
The levonorgestrel IUD allows for effective menstrual suppression without exogenous estrogen exposure, making it a suitable option for teens with contraindications to estrogen 1
Combined Oral Contraceptives (COCs) provide decreased menstrual cramping and blood loss, with low-dose pills (containing 30-35 μg ethinyl estradiol) and levonorgestrel or norgestimate commonly recommended for adolescents 3, 4, 5

Depot Medroxyprogesterone Acetate (DMPA) provides improvement in dysmenorrhea and protection against iron-deficiency anemia, with convenient injection every 13 weeks 1
DMPA may cause reductions in bone mineral density (BMD), though substantial recovery occurs after discontinuation, and requires counseling about menstrual irregularities to improve continuation rates 1, 4

For teens with heavy menstrual bleeding, consider starting with a monophasic COC containing 30-35 μg of ethinyl estradiol and a progestin like levonorgestrel or norgestimate, with extended or continuous cycle regimens particularly appropriate for teens with heavy bleeding or anemia 3, 5
The levonorgestrel IUD is useful for adolescents with medical conditions requiring long-term menstrual suppression where estrogen is contraindicated, with no negative effect on long-term fertility 1, 3
It is essential to recommend calcium (1300 mg) and vitamin D (600 IU) daily for teens using DMPA, and to discuss the need for consistent condom use for STI protection regardless of contraceptive method chosen 4, 6

The use of oral contraceptives is associated with decreased risk for iron deficiency, as they reduce menstrual blood loss, according to the Centers for Disease Control and Prevention 7, 8
Depot Medroxyprogesterone Acetate (DMPA) provides improvement in dysmenorrhea and protection against iron-deficiency anemia, with convenient injection every 13 weeks, as recommended by the Centers for Disease Control and Prevention 9
Heavy menstrual blood loss (≥80 mL/month) is an important risk factor for iron-deficiency anemia, affecting approximately 10% of women in the United States, as reported by the Centers for Disease Control and Prevention 7, 8
Only one-fourth of adolescent girls meet the recommended dietary allowance for iron through diet, highlighting the need for supplementation or reduction of menstrual blood loss, according to the Centers for Disease Control and Prevention 7, 8
Schedule follow-up to assess improvement in menstrual bleeding and iron status, as recommended by the Centers for Disease Control and Prevention 9, 10